STOCK TITAN

MedAvail Holdings, Inc. - MDVL STOCK NEWS

Welcome to our dedicated page for MedAvail Holdings news (Ticker: MDVL), a resource for investors and traders seeking the latest updates and insights on MedAvail Holdings stock.

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a pioneering pharmacy technology company that has transformed prescription medication dispensing through its flagship product, the MedAvail MedCenter®.

MedAvail's core business revolves around designing and manufacturing automated dispensing and medication management technologies. The MedCenter is essentially a pharmacist-controlled automated prescription medicine dispensing vault, akin to an ATM, intended for deployment in various healthcare settings like hospitals, pharmacies, medical clinics, and Federally Qualified Health Centers (FQHCs).

Utilizing advanced robotics, two-way video teleconferencing, and a secure network for patient medical information, the MedCenter streamlines the prescription dispensing process. This integration allows for efficient MedCenter deployments, significantly enhancing the partner and patient experience.

MedAvail's technology aims to promote patient drug adherence, which in turn leads to better health outcomes. Their turnkey, in-clinic pharmacy services are currently utilized in both primary care and urgent care settings.

MedAvail has recently made notable strides in the industry, having integrated with Epic and Willow to improve service delivery. These integrations are anticipated to further streamline operations and enhance the overall user experience.

To learn more about MedAvail's innovative solutions and their impact on improving healthcare outcomes, visit www.medavail.com.

Rhea-AI Summary
MedAvail Holdings, Inc. (MDVL) expands its presence among Federally Qualified Health Centers (FQHCs) by entering into an agreement with St. Thomas Community Health Centers for the deployment of two M4 MedCenter kiosks. This partnership aims to provide affordable health care to underserved communities across the New Orleans metropolitan area, utilizing 340B savings to improve medication access and adherence, and improve health outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
none
-
Rhea-AI Summary
MedAvail Holdings, Inc. (Nasdaq: MDVL) received a delinquency notification letter from Nasdaq, indicating non-compliance with filing its Quarterly Report on Form 10-Q. The company has 60 days to submit a plan to regain compliance, with a potential extension until May 13, 2024. The delinquency has no immediate effect on the stock listing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.67%
Tags
none
-
Rhea-AI Summary
MedAvail Holdings, Inc. (Nasdaq: MDVL) has entered an agreement with Pharmacy Fund 1 to deploy ten M4 MedCenter kiosks at ASP Cares Pharmacy in Las Vegas. The first three deployments are planned for early 2024. This represents an expansion of MedAvail's successful relationship with Oak Lawn Pharmacy in Dallas. The agreement aims to improve patient access to medications and is expected to result in efficient and timely deployments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.45%
Tags
none
Rhea-AI Summary
MedAvail CEO to participate in H.C. Wainwright conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
conferences
-
Rhea-AI Summary
MedAvail Holdings, Inc. reports Q2 2023 financial results, with net revenue of $405,000 and the placement of two new MedCenters. The company expects to place a total of 25 net new revenue generating MedCenters in 2023. MedAvail's pipeline is growing in primary care and urgent care channels, and they have expanded into Federally Qualified Health Centers. The integration with Texas Health Resources has had a positive impact on the pipeline. The company is well financed and expects to achieve operating cash flow breakeven in 2025 without additional equity financings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.26%
Tags
-
Rhea-AI Summary
MedAvail Holdings, Inc. (Nasdaq: MDVL) has entered an agreement with Oak Lawn Pharmacy to deploy ten M4 MedCenter kiosks across Texas. At least two kiosks will be deployed in 2023, with the remainder within 24 months. Oak Lawn will fund the setup costs. The partnership aims to improve medication access and patient outcomes in Texas, particularly in rural areas.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3%
Tags
none
Rhea-AI Summary
MedAvail Holdings, Inc. (Nasdaq: MDVL) has announced a 1-for-50 reverse stock split of its outstanding shares of common stock to regain compliance with the Minimum Bid Price Requirement of $1.00 per share for continued listing on The Nasdaq Capital Market. The reverse stock split reduces the number of shares from approximately 81 million to approximately 1.6 million shares, with adjustments made to outstanding warrants, stock options, and other equity awards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.2%
Tags
none
-
Rhea-AI Summary
MedAvail Holdings, Inc. reports Q1 2023 financial results, reaffirms full-year guidance. Pipeline continues to grow with new and existing partners. Cost savings opportunities identified. Regulatory landscape evolving in favor of remote kiosk pharmacy dispensing. Company expects total revenue of $3 million and gross margins in excess of 60% for 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.4%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences earnings

FAQ

What is the market cap of MedAvail Holdings (MDVL)?

The market cap of MedAvail Holdings (MDVL) is approximately 2.9M.

What is MedAvail Holdings, Inc.?

MedAvail Holdings, Inc. is a pharmacy technology company that designs and manufactures automated dispensing and medication management technologies.

What is the MedAvail MedCenter®?

The MedAvail MedCenter® is an automated prescription medicine dispensing vault controlled by pharmacists, similar to an ATM.

Where is the MedCenter deployed?

The MedCenter is deployed in hospitals, pharmacies, medical clinics, primary care, urgent care settings, and Federally Qualified Health Centers (FQHCs).

How does MedAvail promote patient drug adherence?

MedAvail promotes patient drug adherence through its efficient and convenient MedCenter dispensing system, which leads to better health outcomes.

What technologies does the MedCenter use?

The MedCenter uses advanced robotics, two-way video teleconferencing, and a secure network for patient medical information.

What recent integrations has MedAvail achieved?

MedAvail has integrated with Epic and Willow to streamline MedCenter deployments and improve partner and patient experiences.

Who should use the MedAvail MedCenter?

The MedCenter is beneficial for hospitals, pharmacies, medical clinics, and Federally Qualified Health Centers seeking efficient prescription dispensing solutions.

Where can I learn more about MedAvail?

You can learn more about MedAvail and its innovative solutions by visiting their website at www.medavail.com.

How can I contact MedAvail Investor Relations?

You can contact MedAvail Investor Relations through Steven Halper and Caroline Paul at ir@medavail.com.

What stock symbol does MedAvail trade under?

MedAvail trades under the symbol MDVL on NASDAQ.

MedAvail Holdings, Inc.

Nasdaq:MDVL

MDVL Rankings

MDVL Stock Data

2.91M
380.04k
0.38%
87.06%
0.64%
Pharmaceutical Retailers
Healthcare
Link
United States
Phoenix